WOMENS GENTLE LAXATIVE

Product NDC
61715-039
11-digit product format
617150039
Labeler code
61715
Product ID
61715-039_ecc01437-3b42-4caf-804f-acc5dc958fcc
Type
HUMAN OTC DRUG
Nonproprietary name
Bisacodyl
Dosage form
TABLET, COATED
Route
ORAL
Labeler
Preferred Plus (Kinray)
Application
part334
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2010-08-02
Marketing end
2022-12-30
Substance
BISACODYL
Active strength
5 mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct61715-039DDiscontinued by firm2026-10-05
excluded packagepackage61715-03961715-039-30DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage61715-039-30d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage61715-039-30f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage61715-039-302ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage61715-039-30a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage61715-039-30cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage61715-039-30cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage61715-039-30302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage61715-039-30ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage61715-039-300efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage61715-039-30ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage61715-039-30367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage61715-039-30557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BISACODYLACTIVE INGREDIENT10X0709Y6IWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
BISACODYLACTIVE MOIETY10X0709Y6IWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
ACACIAINACTIVE INGREDIENT5C5403N26OWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
CALCIUM SULFATE ANHYDROUSINACTIVE INGREDIENTE934B3V59HWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
D&C RED NO. 7INACTIVE INGREDIENTECW0LZ41X8WOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675WOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357WOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST)INACTIVE INGREDIENT87Y6436BKRWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
KAOLININACTIVE INGREDIENT24H4NWX5COWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30WOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
POVIDONESINACTIVE INGREDIENTFZ989GH94EWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
SHELLACINACTIVE INGREDIENT46N107B71OWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4WOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
SODIUM STARCH GLYCOLATE TYPE A CORNINACTIVE INGREDIENTAG9B65PV6BWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
SUCROSEINACTIVE INGREDIENTC151H8M554WOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
TALCINACTIVE INGREDIENT7SEV7J4R1UWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPWOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2
TRIACETININACTIVE INGREDIENTXHX3C3X673WOMENS GENTLE LAXATIVE (BISACODYL) TABLET, COATED [PREFERRED PLUS (KINRAY)]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
61715-039-30617150039302 BLISTER PACK in 1 CARTON (61715-039-30) > 15 TABLET, COATED in 1 BLISTER PACK2 blister pack2010-08-022022-12-30NoNoCurrent